Equities

Imricor Medical Systems Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
IMR:ASX

Imricor Medical Systems Inc

Actions
Health CareMedical Equipment and Services
  • Price (AUD)2.06
  • Today's Change0.06 / 3.00%
  • Shares traded277.77k
  • 1 Year change+42.07%
  • Beta0.6568
Data delayed at least 20 minutes, as of Feb 16 2026 05:10 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Imricor Medical Systems, Inc. is a developer of magnetic resonance imaging (MRI)-compatible medical devices which can be used to carry out real-time interventional cardiac magnetic resonance imaging (iCMR) cardiac ablation procedures. The Company develops MRI-compatible products for cardiac catheter ablation procedures. The Vision-MR Ablation Catheter is the Company’s prime product offering, specifically designed to work under real-time MRI guidance. Its other products include Advantage-MR EP Recorder/Stimulator System, the Vision-MR Diagnostic Catheter and Vision-MR Dispersive Electrode. Advantage-MR EP Recorder/Stimulator System provides technology that allows the physician to utilize both the EP recording system and a cardiac stimulator while ablating within the iCMR environment. It sells its capital and consumable products to hospitals and clinics for use in iCMR labs, in which ablation procedures using the Vision-MR Ablation Catheter can be performed.

  • Revenue in AUD (TTM)1.06m
  • Net income in AUD-50.76m
  • Incorporated2006
  • Employees--
  • Location
    Imricor Medical Systems Inc400 GATEWAY BLVDBURNSVILLE 55337-2559United StatesUSA
  • Phone+1 (952) 818-8400
  • Websitehttps://imricor.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Epiminder Ltd-100.00bn-100.00bn147.16m---------------------------------------------------93.22---99.64------
Somnomed Ltd111.52m-3.46m154.00m300.00--3.2867.251.38-0.0163-0.01630.52620.21471.486.537.25---4.58-9.15-6.76-13.4659.8660.62-3.10-6.891.25-0.60670.1475--21.6314.2471.77--12.72--
EMvision Medical Devices Ltd5.63m-9.81m167.29m----16.58--29.72-0.1148-0.11480.06590.10860.2847--694.01---49.59-47.15-58.91-58.42-----174.21-105.97---93.340.2758---51.3141.83-259.23------
Lumos Diagnostics Holdings Ltd17.49m-10.13m206.24m----22.40--11.79-0.0147-0.01470.02570.01160.52057.044.91---30.15-40.19-54.60-61.1662.9552.57-57.93-132.460.6816-10.690.5315--11.4017.1216.40---61.58--
Aroa Biosurgery Ltd76.96m-1.55m243.56m261.00--3.09145.163.16-0.0045-0.00450.2230.22790.84321.563.08---1.70-8.53-1.85-9.7585.0782.71-2.01-15.205.740.31420.0706--22.6327.5664.12--14.62--
Orthocell Ltd8.85m-8.57m249.60m----15.37--28.20-0.0375-0.03750.03970.05990.28622.319.20---27.70-28.14-34.17-33.4768.9871.87-96.78-167.824.78--0.0381--36.4161.65-19.30--45.43--
Saluda Medical Inc-100.00bn-100.00bn262.10m--------------------------------------------------36.13---52.62------
Paragon Care Ltd3.62bn20.57m322.78m0.0015.700.97866.400.08920.01240.01242.180.19933.0211.9010.33--1.721.794.474.079.048.900.56880.60810.61551.770.4699--21.7273.23151.52--18.34--
EchoIQ Ltd101.41k-13.26m343.24m----14.88--3,384.66-0.0226-0.02260.00020.03530.0064--0.6446---83.87-68.78-89.84-81.95-----13,078.12-3,892.98----0.00--127.89-31.65-145.19---16.56--
EBR Systems Inc961.90k-63.22m366.78m----6.72--381.31-0.1688-0.16880.00250.12120.0074--0.4935---48.75-60.71-53.75-74.7645.20---6,572.14--7.01-15.000.5131-------16.44--2.46--
Polynovo Ltd127.73m13.21m635.58m301.0048.247.6339.954.980.01910.01910.18370.12051.080.3675.88424,352.2011.192.1714.292.7196.6394.8910.352.102.257.870.17070.0021.9641.91151.17--9.45--
Imricor Medical Systems Inc1.06m-50.76m641.89m----19.68--607.81-0.1877-0.18770.00380.10160.02371.132.64---113.72-103.39-123.12-119.90-133.44-154.65-4,806.09-2,687.8525.62-1.110.5073--55.868.44-31.23---26.55--
Data as of Feb 16 2026. Currency figures normalised to Imricor Medical Systems Inc's reporting currency: Australian Dollar AUD

Institutional shareholders

0.74%Per cent of shares held by top holders
HolderShares% Held
Investors Mutual Ltd.as of 31 Jan 20262.38m0.74%
Data from 31 Jan 2026 - 31 Jan 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.